RIM
IDXX icon

Reliant Investment Management’s Idexx Laboratories IDXX Stock Holding History

Reliant Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,717
Closed -$3.56M – 58
2022
Q4 		$3.56M Sell
8,717
-592
-6% -$230K 2.12% 29
2022
Q3 		$3.03M Sell
9,309
-217
-2% -$79.7K 2.16% 27
2022
Q2 		$3.34M Sell
9,526
-837
-8% -$341K 2.35% 25
2022
Q1 		$5.67M Sell
10,363
-223
-2% -$117K 2.91% 16
2021
Q4 		$6.97M Buy
10,586
+435
+4% +$273K 2.87% 10
2021
Q3 		$6.31M Sell
10,151
-558
-5% -$375K 3.14% 9
2021
Q2 		$6.76M Sell
10,709
-490
-4% -$271K 3.11% 9
2021
Q1 		$5.48M Buy
11,199
+259
+2% +$130K 2.68% 12
2020
Q4 		$5.47M Sell
10,940
-225
-2% -$101K 2.92% 13
2020
Q3 		$4.39M Buy
11,165
+800
+8% +$296K 2.82% 17
2020
Q2 		$3.42M Buy
+10,365
New +$3M 2.49% 20

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Reliant Investment Management's IDXX Position: Q1 2023 in Review

Reliant Investment Management sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 8,717 shares — an estimated $3.56M sold.

Reliant Investment Management first reported a position in IDXX in Q2 2020 and held it in 11 quarters. The position peaked at $6.97M in Q4 2021. 1,056 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

  • Reliant Investment Management reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
  • Reliant Investment Management sold 8,717 Idexx Laboratories shares in Q1 2023, an estimated $3.56M.
  • Reliant Investment Management first reported a position in Idexx Laboratories in Q2 2020 and held it in 11 quarters.
  • Reliant Investment Management's Idexx Laboratories position peaked at $6.97M in Q4 2021.
  • 1,056 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on Reliant Investment Management's 13F filing for Q1 2023, filed 20 Apr 2023.